Quick Answer
LEXICON PHARMACEUTICALS, INC. reported Total Revenue of $49.80 million for fiscal year 2025.
LEXICON PHARMACEUTICALS, INC. Total Revenue — Annual History
| Fiscal Year | Total Revenue | YoY Change |
|---|---|---|
| 2025 | $49.80M | +60.2% |
| 2024 | $31.08M | +2481.5% |
| 2023 | $1.20M | +766.2% |
| 2022 | $139.0K | -53.4% |
| 2021 | $298.0K | -98.8% |
| 2020 | $24.00M | -92.5% |
| 2019 | $322.07M | +409.5% |
| 2018 | $63.21M | -31.1% |
| 2017 | $91.69M | +15.7% |
| 2016 | $79.26M | -39.0% |
| 2015 | $130.01M | +468.9% |
| 2014 | $22.85M | +928.5% |
| 2013 | $2.22M | +104.0% |
| 2012 | $1.09M | -41.1% |
| 2011 | $1.85M | -62.3% |
| 2010 | $4.91M | -54.1% |
| 2009 | $10.70M | — |
Quarterly Total Revenue
| Quarter Ending | Total Revenue | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $14.18M | +710.4% | -50.9% |
| June 30, 2025 | $28.87M | +1652.6% | +2187.3% |
| March 31, 2025 | $1.26M | +11.7% | -27.9% |
| September 30, 2024 | $1.75M | +980.2% | +6.3% |
| June 30, 2024 | $1.65M | +419.6% | +45.8% |
| March 31, 2024 | $1.13M | +4608.3% | +597.5% |
| September 30, 2023 | $162.0K | +315.4% | -48.9% |
| June 30, 2023 | $317.0K | +805.7% | +1220.8% |
- LEXICON PHARMACEUTICALS, INC. showed an increase of +60.2% in Total Revenue compared to the prior fiscal year.
- Over the 2009–2025 period, LEXICON PHARMACEUTICALS, INC.’s total revenue has grown by 365.4% (from $10.70 million to $49.80 million).
- The most recent figure is from LEXICON PHARMACEUTICALS, INC.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 5, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: